IQVIA Holdings/IQV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About IQVIA Holdings
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Ticker
IQV
Sector
Healthcare
Trading on
NYSE
Industry
Life Sciences Tools and Services
Headquarters
Durham, United States
Employees
87,000
Website
www.iqvia.com
IQVIA Holdings Metrics
BasicAdvanced
$38B
Market cap
28.46
P/E ratio
$7.33
EPS
1.54
Beta
-
Dividend rate
Price and volume
Market cap
$38B
Beta
1.54
Financial strength
Current ratio
0.876
Quick ratio
0.781
Long term debt to equity
205.281
Total debt to equity
219.01
Interest coverage (TTM)
3.02%
Management effectiveness
Return on assets (TTM)
5.03%
Return on equity (TTM)
22.11%
Valuation
Price to earnings (TTM)
28.46
Price to revenue (TTM)
2.53
Price to book
5.99
Price to tangible book (TTM)
-2.95
Price to free cash flow (TTM)
23.47
Growth
Revenue change (TTM)
3.97%
Earnings per share change (TTM)
31.67%
3-year revenue growth
7.84%
3-year earnings per share growth
51.67%
What the Analysts think about IQVIA Holdings
Analyst Ratings
Majority rating from 22 analysts.
IQVIA Holdings Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.7B
-3.39%
Net income
$288M
-38.59%
Profit margin
7.70%
-36.47%
IQVIA Holdings Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.43
$2.49
$2.84
$2.54
-
Expected
$2.37
$2.44
$2.82
$2.48
$2.57
Surprise
2.47%
1.88%
0.68%
2.40%
-
IQVIA Holdings News
AllArticlesVideos
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
Business Wire·2 months ago
IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
Business Wire·2 months ago
IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for IQVIA Holdings stock?
IQVIA Holdings (IQV) has a market cap of $38B as of July 03, 2024.
What is the P/E ratio for IQVIA Holdings stock?
The price to earnings (P/E) ratio for IQVIA Holdings (IQV) stock is 28.46 as of July 03, 2024.
Does IQVIA Holdings stock pay dividends?
No, IQVIA Holdings (IQV) stock does not pay dividends to its shareholders as of July 03, 2024.
When is the next IQVIA Holdings dividend payment date?
IQVIA Holdings (IQV) stock does not pay dividends to its shareholders.
What is the beta indicator for IQVIA Holdings?
IQVIA Holdings (IQV) has a beta rating of 1.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell IQVIA Holdings stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.